Table 4.
Resources consumed for each phase of ASLND or ALND including 1 month follow-up
| ASLND (n = 817) | ALND (n = 140) | P | |
| Preoperative phase | |||
| Preoperative diagnostic | |||
| Realized and obtained (%) | 97 | 89 | 0.0001 |
| Average isotopic dose injected (MBq) | 41.5 | – | – |
| Preoperative scintigraphy frequency (%) | 80 | ||
| Average scintigraphy per patienta (mean, standard deviation) | 1.2 (σ = 0.4) | – | – |
| Detection of sentinel lymph node (%) | 97 | – | – |
| Subtotal cost (€, 2007) | 582 (σ = 213) | 176 (σ = 141) | 0.001 |
| Operative and hospitalization phase | |||
| Frequency of intraoperative analysis (%) | 77 | – | – |
| Mean duration of pathological analysis (min) | 18 | – | – |
| Mean time laboratory technician (min) | 21 | – | – |
| Mean occupation time operating room (min) | 98 (σ = 34) | 106 (σ = 31) | 0.01 |
| Complications during hospitalization | 17 (2.1%) | 7 (5%) | 0.07 |
| Due to breast surgery | 16 | 3 | |
| Due to axillary surgery | 1 | 4 | |
| Mean length of hospital stay (days) | 3.8 (σ = 1.4) | 6.4 (σ = 3.2) | 0.000 |
| Without breast complications | 3.79 (σ = 1.3) | 6.4 (σ = 3.2) | 1 |
| Total costs excluding follow-up (€, 2007) | 3007 (σ = 687) | 3340 (σ = 1174) | 0.002 |
| Hospital follow-up (1 month) | |||
| Total number of surgical reintervention | 253 (31%) | 24 (17%) | 0.001 |
| Number of second surgery | 242 (30%) | 23 (16%) | 0.001 |
| For breast | 110 (13%) | 23 (16%) | – |
| For axillary nodes | 132 (16%) | 0 | – |
| Mean length of stay (days) for second surgery | 4.5 (σ = 2) | 5.6 (σ = 5) | 0.3 |
| For breast | 4 (σ = 3) | 5.6 (σ = 5) | |
| For axillary nodes | 5.2 (σ = 2.2) | – | |
| Number of third surgery | 11 (+1%) | 1 (<1%) | – |
| For breast margins | 10 | 1 | – |
| For axillary nodes | 1 | 0 | – |
| Mean length of stay (days) for third surgery | 4.4 (σ = 2.5) | 8 | |
| For breast | 4.5 (σ = 2) | 8 | |
| For axillary nodes | 4 | – | |
| Number of patients who have had complications at 1 month after the first surgery | 130 (16%) | 41 (29%) | 0.0001 |
| Localization of complication at the first surgery | |||
| Breast | 82 (10%) | 18 (12%) | 0.049 |
| Axilla | 49 (6%) | 23 (16%) | 0.0001 |
| Type of complicationsb | |||
| Abcess and hematoma | 40 (5%) | 5 (4%) | – |
| Seroma aspiration | 49 (6%) | 26 (19%) | – |
| Lymphedema | 0 | 2 (2%) | – |
| Othersc | 40 (5%) | 5 (4%) | – |
| Number of complications leading to another hospital stayd | 9 | 2 | – |
| Breast margin (and others) complications | 8 | 2 | |
| For axillary node complications | 1 | 0 | |
| Mean length of stay (days) for complication | 5.3 (σ = 4) | 2 (σ = 1) | – |
| For breast margins | 5 (σ = 3.8) | 2 (σ = 1) | |
| For axillary nodes | 6 | – | |
| Number of seroma aspiration at hospital | 0.5 (σ = 1.3) | 1.2 (σ = 12.8) | 0.0003 |
| Number of physiotherapist visits at hospital | 2 (σ = 5.9) | 6.3 (σ = 8.7) | 0.001 |
| Number of surgeon visits at hospital | 1.3 (σ = 1.3) | 1.3 (σ = 1.2) | 0.75 |
| Total costs including follow-up (€, 2007) | 3.7 (σ = 1.4) | 3.8 (σ = 20) | 0.62 |
a
For patients who had a scintigraphy.
b
Axillary and breast complications.
c
Discharge, erythema, brides, bruise etc.
d
Complications following the first, second or third surgery.
ASLND, axillary sentinel lymph node dissection; ALND, axillary lymph node dissection.